IL18 and melanoma: Importantly, the ability of WT IL18 to suppress the growth of B16-F10 melanomas in vivo was retained in Il18r1−/− mice (which lack the main IL18 receptor), further demonstrating that this does not involve pro-inflammatory signaling by mIL18.1